ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,609Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 143

$895K Total Retail Price of All Prescriptions

Rank: 4 out of 143

542 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,916 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 481 372 1 1
LEVOTHYROXINE SODIUM 478 347 2 3
FUROSEMIDE 441 349 3 6
SIMVASTATIN 405 303 4 2
OMEPRAZOLE 383 283 5 5
ATORVASTATIN CALCIUM 363 313 6 7
AMLODIPINE BESYLATE 303 239 7 4
METFORMIN HCL 299 195 8 8
PRAVASTATIN SODIUM 265 182 9 9
HYDROCHLOROTHIAZIDE 265 204 9 10
MELOXICAM 197 140 11 78
TRAMADOL HCL 196 161 12 16
ATENOLOL 192 150 13 11
WARFARIN SODIUM 186 120 14 15
METOPROLOL SUCCINATE 182 151 15 14
METOPROLOL TARTRATE 175 139 16 12
GABAPENTIN 165 132 17 18
CITALOPRAM HBR 160 114 18 25
LOSARTAN POTASSIUM 147 128 19 19
CIPROFLOXACIN HCL 145 93 20 58
RANITIDINE HCL 144 91 21 41
HYDROCODONE-ACETAMINOPHEN 142 70 S3 22 20
ROPINIROLE HCL 141 96 23 90
POTASSIUM CHLORIDE 137 89 24 34
CRESTOR 135 95 25 17
OXYCODONE HCL 134 40 S2 26 29
GLIPIZIDE ER 129 95 27 75
TAMSULOSIN HCL 125 117 28 28
BISOPROLOL FUMARATE 120 94 29 67
CLOPIDOGREL 120 98 29 33
ADVAIR DISKUS 119 93 31 42
ZOLPIDEM TARTRATE 115 77 32 13
ISOSORBIDE MONONITRATE ER 112 94 33 44
CARVEDILOL 111 91 34 22
POLYETHYLENE GLYCOL 3350 104 58 35 45
PLAVIX 103 91 36 51
LOVASTATIN 96 69 37 50
GLIPIZIDE 96 77 37 55
PANTOPRAZOLE SODIUM 91 75 39 43
NEXIUM 91 64 39 32
OXYCODONE-ACETAMINOPHEN 90 61 S2 41 56
GLIPIZIDE XL 87 79 42 126
NOVOLOG MIX 70-30 FLEXPEN 87 79 42 133
DIGOXIN 85 82 44 71
FLUTICASONE PROPIONATE 85 47 44 37
OXYCODONE HCL-ACETAMINOPHEN 84 61 S2 46 73
PAROXETINE HCL 83 70 47 79
PROAIR HFA 83 50 47 48
TRICOR 81 58 49 71
FELODIPINE ER 80 54 50 82
SERTRALINE HCL 79 38 51 23
LIPITOR 77 67 52 57
QUINAPRIL HCL 76 59 53 124
SPIRIVA 72 46 54 38
MECLIZINE HCL 70 68 55 145
ALLOPURINOL 69 65 56 39
NIASPAN 68 44 57 105
DIOVAN 67 53 58 26
FINASTERIDE 63 63 59 97
KLOR-CON M20 62 46 60 69
CYCLOBENZAPRINE HCL 62 40 R 60 77
CELEBREX 61 56 62 70
TOPROL XL 61 56 62 154
SYNTHROID 59 50 64 24
GLIMEPIRIDE 58 52 65 27
DOXYCYCLINE HYCLATE 56 44 66 113
VERAPAMIL ER 55 37 67 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 44 68 121
CARISOPRODOL 54 41 R 68 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 39 70 21
HYDRALAZINE HCL 51 51 71 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.